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Abstract
Background: Solid tumors are heterogeneous in composition. Cancer stem cells
(CSCs) are believed to drive tumor progression, but the relative frequencies of CSCs
versus non-stem cancer cells span wide ranges even within tumors arising from the
same tissue type. Tumor growth kinetics and composition can be studied through
an agent-based cellular automaton model using minimal sets of biological
assumptions and parameters. Herein we describe a pivotal role for the generational
life span of non-stem cancer cells in modulating solid tumor progression in silico.
Results: We demonstrate that although CSCs are necessary for progression, their
expansion and consequently tumor growth kinetics are surprisingly modulated by
the dynamics of the non-stem cancer cells. Simulations reveal that slight variations in
non-stem cancer cell proliferative capacity can result in tumors with distinctly
different growth kinetics. Longer generational life spans yield self-inhibited tumors, as
the emerging population of non-stem cancer cells spatially impedes expansion of
the CSC compartment. Conversely, shorter generational life spans yield persistence-
limited tumors, with symmetric division frequency of CSCs determining tumor
growth rate. We show that the CSC fraction of a tumor population can vary by
multiple orders of magnitude as a function of the generational life span of the non-
stem cancer cells.
Conclusions: Our study suggests that variability in the growth rate and CSC content
of solid tumors may be, in part, attributable to the proliferative capacity of the non-
stem cancer cell population that arises during asymmetric division of CSCs. In our
model, intermediate proliferative capacities give rise to the fastest-growing tumors,
resulting in self-metastatic expansion driven by a balance between symmetric CSC
division and expansion of the non-stem cancer population. Our results highlight the
importance of non-stem cancer cell dynamics in the CSC hypothesis, and may offer a
novel explanation for the large variations in CSC fractions reported in vivo.
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Background
The cancer stem cell hypothesis suggests that a subset of cells in a tumor is uniquely
capable of driving disease. Definitively identifying cancer stem cells is often hailed as
the Holy Grail of cancer research, as they are believed to be the sole initiator and dri-
ver of tumor growth, and thus their eradication may offer targeted tumor treatment.
Characterization of cancer stem cells and quantification of their frequency within solid
tumors, however, are topics still in their infancy and subjects of debate. Computational
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assessing the relative contributions of basic cellular kinetics to macroscopic growth
dynamics and composition of solid tumors. Two tumors, presenting the same cellular
population size at clinical detection, can comprise very different subsets of cell types.
As a result, the prognosis downstream of presentation could be very different. Unex-
pectedly, although cancer stem cells are the engine of tumor progression, the prolifera-
tive capacity of non-stem cancer cells appears to be modulating cancer stem cell
kinetics and thus overall tumor progression dynamics. Understanding the oft-neglected
contribution of the non-stem population within a heterogeneous tumor will help
explain the large variations in cancer stem cell frequency reported in the literature,
and ultimately help guide the design of appropriate treatments for patients with differ-
ent disease presentations.
Introduction
The cancer stem cell (CSC) hypothesis is a conceptual construct of tumor initiation,
composition, and clinical response. Tumors are heterogeneous populations comprising
clonogens (cells that can repeatedly initiate and maintain tumor clones) and cells
devoid of clonogenic potential. The CSC hypothesis emerged following observation
that the frequency of such clonogens can be remarkably low in solid tumors. Most
ongoing discussions involve measurements of the frequency of CSCs, as broad ranges
of CSC fractions often spanning multiple orders of magnitude have been observed in
human solid tumors of various organ types [1]. CSCs are defined as immortal, posses-
sing the ability to divide either symmetrically to yield two identical immortal cancer
stem cells; or asymmetrically, to simultaneously self-renew and yield mortal non-stem
cancer cells (CCs) with finite replicative potential. Each successive division of CCs
reduces their remaining proliferative capa c i t yb yaf i n i t ea m o u n t ,p e r h a p st h r o u g ha
mechanism such as telomere shortening [2,3] (Figure 1). Eventually, progeny cancer
cells without any remaining replicative potential arise and subsequent division attempts
result in cell death.
The interplay of CSCs and CCs in tumor progression lends itself to quantitative
agent-based modeling of tumor behavior using cellular automata, an established
approach to analyze complex system dynamics and test systemic response to perturba-
tion under a minimal set of rules and constraints [4-8]. Of particular intrigue is the
paradoxical dependence of tumor progression on cell death within the CSC hypothesis,
and the apparent disconnect between the clinical strategy of inciting cell death through
chemical or radiological assault and the mathematical behavior of an untreated system
that might well be self-limiting [9]. We have shown previously that a system looking
solely at the balance between cell proliferation, migration, and death can be sufficient
to explain anomalous features of the growth kinetics and morphology of simulated
tumors [10]. In this model, without sufficient migration capability, a CSC may quickly
become surrounded and spatially inhibited by non-stem CC progeny, and thus able to
initiate only a clone of self-limiting size [11]. The resulting tumor achieves a pseudo-
steady dormant state, characterized by a balance between cell death of CC with
exhausted proliferative capacity at the periphery and subsequent proliferation of pre-
viously quiescent CC. Growth beyond the initial clone is impeded by the lack of space
available for the CSC to divide potentially symmetrically to seed a new clone nearby -
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[10,12]. Herein we describe further exploration of cell-cell interactions underlying
these phenomena toward describing tumor growth kinetics and CSC fraction as a func-
tion of the generational life span of the CCs. Depending on this inherited maximum
proliferative capacity, CCs generate clonal population sizes that contribute to form
smaller or larger tumors, respectively enabling or inhibiting CSC proliferation. Without
sufficient telomerase activity, cells progressively shorten telomeres upon each division,
eventually leading to terminal failure to replicate chromosomes and cell death [13].
The number of cell divisions is likely to be dependent on the function, morphology,
age and developmental history of the specific organ. However, the specificity of telo-
mere length to tissue type and the process of telomere shortening at a measurable rate
[14] suggests that the remaining proliferative capacity of a given cell can be quantita-
tively modeled as the number of sequential mitoses until death (Figure 1). Agent-based
models can capture the interactive consequences of cell-intrinsic properties and tumor
population dynamics while allowing for the distinction of the participating CSC and
CC compartments. Through stochastic simulations, we explore how altering CC gen-
erational life span influences tumor growth kinetics and CSC prevalence. CCs are
thought to be the dominant population in a tumor, yet a large CC population impairs
tumor progression in silico [9]. Therefore, non-linear modulation of tumor kinetics by
the generational life span of CCs is expected. We identify optimal parameter values for
tumor progression and inhibition, as predicted by the model, and discuss their biologi-
cal applicability.
Figure 1 Cancer stem cells (CSCs, yellow) may divide symmetrically (curved black arrows) to
generate two identical CSCs; or asymmetrically (red arrows) to self-renew and yield a non-stem
cancer cell with a discrete maximum proliferative capacity. Non-stem cancer cells may divide only
symmetrically (straight horizontal black arrows), with both parent and daughter experiencing a decrement
in proliferative capacity. Mortal non-stem cancer cells with exhausted proliferative capacity die upon the
ensuing division attempt. Non-stem cancer cells inherit generational life spans from the parent CSCs,
resulting in a hierarchy depth (red to black gradient) that determines tumor population heterogeneity.
Shown are hierarchical progressions of tumor populations originating from A) a CSC conferring rmax =4
and B) a CSC conferring rmax =1 .
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We extend an established agent-based cellular automaton model [9,10] of CSCs and
CCs interacting in tumor growth. We assume that (i) CSCs are immortal with unlim-
ited replicative potential, (ii) CC maximum proliferative capacity rmax is inherited from
the parent CSC following an asymmetric division, (iii) the probability of symmetric (ps)
and asymmetric (1 - ps) CSC division is constant and stochastic, and (iv) cells require
adjacent available space to migrate or proliferate. Individual cells are equipped with a
cell cycle time of 24 hours and migration speeds of μ = 0, 50, 100, or 150 μm( i . e . ,0 ,
5, 10, or 15 cell widths) per day [15]. We model migration speed as a trait inherent to
a cell. While there are undoubtedly tissue types that naturally demonstrate faster or
slower migration rates associated with the biological function of that organ system, or
that change to a faster migration regime in a context such as wound healing, these tis-
sue-level observations can be emergent properties of an agent-based model rather than
imposed behaviors. How cell migration speed and environmental chemotactic gradients
modulate tumor progression has been discussed elsewhere [10,16].
We investigate proliferative capacities of CCs (that are first generation progeny of
CSCs) of rmax = {0-10}. To reflect the low frequency at which CSCs are observed [1],
we set the probability of symmetric CSC division to ps = 1% or 10%. Symmetric CSC
division yields two immortal CSCs. Asymmetric CSC division preserves the parent
CSC and creates a CC with exactly proliferative capacity rmax. While the CSC exhibits
an immortal phenotype, through asymmetric division it endows the daughter CC with
a discrete, finite replicative potential ostensibly proportional to remaining telomere
length. This uniquely defines a maximum number of sequential mitoses this CC may
undergo before exhausting its replicative potential. CSCs of different tissue origin and
age may vary in telomere length and thus bequeath different maximum replicative
potentials (rmax) to their CC offspring. While fetal diploid cell strains in culture
demonstrate a high number of divisions possible before mitotic arrest and culture
degeneration (50 ± 10 population doublings, termed the “Hayflick Limit” [17,18]), 18
divisions have been reported for neutrophil granulocytes [19], and colonic crypt pro-
genitors complete only four to six divisions [20]. Recent data indicates that that cancer
cells have very short telomeres [21], and with telomere length being indicative of repli-
cative potential, the generational life span of cancer cells might be shorter than widely
assumed. CC division yields two CCs with decremented replicative potential rnew =
rparent - 1. Cells that have exhausted their proliferative capacity, i.e. r =0 ,d i eu p o n
the subsequent division attempt and are removed from the simulation. For each set of
conditions, ten independent simulations were performed, each initialized by a single
CSC at the center of a 350 × 350 computational lattice. Each lattice point represents a
dimension of (10 μm)
2 t h a tc a nb eo c c u p i e db yas i n g l ec e l la tm o s t .T h es i m u l a t i o n
time interval is one hour, with the probabilities of a proliferation or migration event
during a given interval being equal to the cell cycle time and migration rate μ divided
by 24 (hours per day). Tumor growth proceeds for five years of simulation time or
until a total population size of 50,000 cells is reached. The stochastic behavior of the
model is governed by the flowchart outlined in Figure 2.
Total number of cancer cells and number of cancer stem cells are recorded at simu-
lated seven-day intervals. Simulation run times on a Quad-core 2.3 GHz Intel Xeon
M a cO Sa n d6 4 - b i tC e n t O Ss e r v e r sr a n g ef rom ten minutes to seven days. Raw data
Morton et al. Theoretical Biology and Medical Modelling 2011, 8:48
http://www.tbiomed.com/content/8/1/48
Page 4 of 13from each simulation are analyzed to generate average growth curves and CSC fraction
in the emerging tumors.
Results
Tumor growth kinetics display non-monotonic dependence on replicative potential
If symmetric CSC division is a rare event (ps = 1%, Figure 3), tumors in which cells are
unable to migrate (μ = 0) require more than 25 simulation years to reach 50,000 cells.
In fact, migration has previously been identified as the pivotal mechanism to defeat
intratumoral space constraints and thus allow for the symmetric CSC division events
necessary for tumor expansion [10]. With low levels of cell migration, i.e. μ = 5 cell
widths per day, tumors in which CCs have proliferative capacities of rmax =0 - 8g r o w
up to 50,000 cells before the five-year simulation threshold. Interestingly, tumors of
cancer cells with longer generational life spans (rmax = 9-10) fail to progress to that
size within five years. Fastest tumor growth to 50,000 cells (115 ± 4 weeks [mean ±
SEM]) is observed at intermediate CC proliferative capacity rmax =5 .O v e rt h es a m e
time interval, lower rmax in CCs yields tumors of 6,008 cells (rmax =0 )t o3 8 , 0 2 7c e l l s
Figure 2 Flow of control in the agent-based model. All cells require available adjacent space to either
migrate or proliferate, or they remain quiescent for the given time interval. Cells that have maturated
through the cell cycle may proliferate, and the resulting progeny will initially occupy a neighboring grid
locus. Non-stem cancer cells with no remaining replicative potential die upon a decision to proliferate,
leaving the previously occupied grid locus empty.
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10, respectively). We define the mean time required for the fastest growing member of
each set of μ-ps p a i r sa st critical (in this case tcritical =1 1 5±4w e e k s ) ,a n ds u m m a r i z e
all results in Table 1.
Similar non-monotonic behavior is also observed at higher cell migration speeds
( F i g u r e3 ;T a b l e1 ) .A tμ = 10, tumors reach 50,000 cells fastest if rmax =7( t critical =
95 ± 5 weeks), with increasing tumor sizes from rmax = 0 (1,977 cells) to rmax =6
(37,152 cells) and decreasing tumor sizes from rmax = 8 (40,066 cells) to rmax =1 0
(7,840 cells). The higher migration rate leads to an increase in the CC generational life
span that facilitates fastest tumor growth. A larger maximum proliferative capacity and
the resulting increase in CC persistence are accommodated by faster cell migration
that loosens the intratumoral spatial confinement. A further increase of cell migration
speed to μ = 15 shifts the fastest growth to tumors with rmax =8( t critical =8 5±6
weeks), again with consistently increasing tumor sizes as rmax increases from 0-8 and
decreasing tumor sizes as rmax increases further.
Non-monotonic dependence on replicative potential is independent of the frequency
of symmetric CSC division. With symmetric CSC division modeled at one order of
magnitude higher frequency (ps = 10%, Figure 4), similar behavior is observed. Consis-
tent with the immortality of CSCs driving macroscopic expansion, tumors grow faster.
Interestingly, fastest tumor growth is observed with lower rmax values compared to less
frequent CSC division (ps = 1%, discussed above). Tumor growth peaks at rmax = 3 for
μ =5 ,a n drmax =5f o rμ =1 0a n dμ =1 5( t critical = 23 ± 1, 17 ± 1 and 14 ± 1 weeks,
respectively).
Figure 3 Simulation results representing the set of conditions at which tumors most rapidly reach
5x104 total cell population when symmetric CSC division frequency ps = 1%. A) Simulation results
representing the set of conditions to most rapidly reach 5 × 10
4 total cell population at symmetric CSC
division frequency ps = 1%. Shown from left to right: migration rates (μ) of 0, 5, 10, and 15 cell widths per
day. Yellow CSCs enlarged for visibility. B) Corresponding growth curves for model tumors at all values of
replicative potential rmax = 0-10. Error bars correspond to SEM (n = 10).
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Intuitively, higher frequencies of symmetric CSC division (ps) lead to larger CSC ratios.
We have shown that intermediate CC generational life spans (rmax) yield the fastest
tumor growth (Figures 5 and 6), and lower or higher rmax values slow tumor progres-
sion. Different CC maximum proliferative capacities on either side of the optimal rmax
for fastest tumor growth lead to tumors of comparable sizes but CSC fractions varying
Table 1 Summary of model tumor growth simulations across all conditions.
Symmetric division
frequency
ps =1 % ps = 10%
Migration rate (cell
widths/day)
μ =0 μ =5 μ =1 0 μ =1 5 μ =0 μ =5 μ =1 0 μ =1 5
Optimum rmax (Figs. 3-4) 0 5 7 8 0 3 5 5
tcritical
(weeks)
1303 ±
19
115 ± 4 95 ± 5 85 ± 6 130 ±
1
23 ± 1 17 ± 1 14 ± 1
CSC Fraction at optimum
rmax
73% 1.8% 0.5% 0.3% 76% 10% 3.1% 3.0%
rmax pairs(Figs. 5-6) n/a 2–83 –10 5–10 n/a 2–53 –71 –9
rmax pairs
Sizes at tcritical
1.7 × 10
4 0.86 ×
10
4
2.1 × 10
4 4.0 ×
10
4
3.8 ×
10
4
1.9 × 10
4
CSC
Fractions
13%–
0.37%
6.5%–
0.10%
1.6%–
0.10%
17%–
3.4%
9.5%–
1.1%
30%–
0.32%
Times to 5 × 10
4 cells
(weeks)
140–172 124–196 102–128 25–25 18–19 18–21
Comparison of tumor growth parameters across symmetric division frequency probabilities (ps) and migration speeds
(μ). For each value of migration rate and probability of symmetric CSC division a certain value for the proliferative
capacity rmax displayed the fastest expansion to the critical size of 5 × 10
4 cells. We defined the time at which that rmax
value reached that size threshold as tcritical (simulation weeks, mean ± SEM, n = 10). Examination of the population sizes
for the other rmax values at tcritical revealed that pairs of rmax values on either side of the optimum had achieved similar
population sizes by tcritical, but in some cases would require distinctly different lengths of time to reach 5 × 10
4 cells.
Figure 4 Simulation results representing the set of conditions at which tumors most rapidly reach
5x104 total cell population when symmetric CSC division frequency ps = 10%. A) Simulation results
representing the set of conditions to most rapidly reach 5 × 10
4 total cell population at symmetric CSC
division frequency ps = 10%. Shown from left to right: migration rates (μ) of 0, 5, 10, and 15 cell widths per
day. Yellow CSCs enlarged for visibility. B) Corresponding growth curves for model tumors at all values of
replicative potential rmax = 0-10. Error bars correspond to SEM (n = 10).
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Page 7 of 13by in some cases multiple orders of magnitude (Table 1). Differing in morphology and
CSC fraction, the growth trajectories of these tumors may cross, eventually going on
to reach the 50,000-cell threshold in different lengths of time despite essentially identi-
cal net growth through the initial period.
When symmetric CSC division was comparatively rare (ps = 1%, Figure 5), tumors
with very distinct morphologies and compositions were apparent on either side of the
optimum rmax for fastest growth. For example, at μ =1 0 ,rmax =3a n drmax =1 0
tumors both reached ~0.86 × 10
4 cells in 95 weeks, but would require 124 or 196
weeks, respectively, to grow to 5 × 10
4 cells. With more frequent symmetric division
(ps = 10%, Figure 6), morphologies were similar, but in some cases the differences in
tumor composition and growth kinetics downstream of tcritical were significant. For
example, when μ = 15, tumors with CC that inherit either rmax =1o rrmax = 9 could
reach ~1.9 × 10
4 cells in 14 weeks, but would require 18 or 21 weeks, respectively, to
Figure 5 Comparison of tumor populations across all generational life spans at tcritical when
symmetric CSC division frequency ps=1%. A) Time to simulation termination when ps = 1% and B)
average population size at tcritical for all rmax values and migration speeds. Non-zero migration values
demonstrate non-monotonic behavior and distinct optima at intermediate values of replicative potential.
At tcritical, model tumors from all rmax values demonstrate a wide range of sizes. C) Matching pairs of
model tumors for non-zero migration values differing only by the replicative potential of the seeding CSC.
In most cases, morphologies are sufficiently distinguishable to enable estimation of CSC content and
therefore the replicative potential of the cell of tumor origin. Top: μ = 5, left rmax = 2, right rmax =8 .
Middle: μ = 10, left rmax = 3, right rmax = 10. Bottom: μ = 15, left rmax = 5, right rmax = 10. Yellow CSCs
enlarged for visibility.
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Page 8 of 13then progress to 5 × 10
4 cells. In this case, morphologies at tcritical were indistinguish-
able but the CSC fractions of 30% (rmax = 1) and 0.32% (rmax = 9) were dramatically
different.
Tumor CSC fractions are dependent on non-stem cancer cell replicative potential
T h ef r a c t i o no fC S C si nt u m o r si sd i r e c t l yd e pendent on the generational life span of
CCs. With increasing rmax, the CSC fraction decreases independently of any other
parameter (Figure 7). When rmax = 0, CCs die upon a first attempt at division, leading
to a large CSC fraction. CCs, however, are still present as they arise from asymmetric
CSC division with high frequency. Without migration, mature tumors comprised over
70% CSC at rmax = 0. Increasing values of rmax d e c r e a s e sC S Cf r a c t i o n st oa sl o wa s
0.1% (rmax = 10, μ = 15, and ps = 1%).
Cancer stem cell fraction fluctuates during early tumor growth due to the stochastic
interpretation of (a)symmetric cancer stem cell division. Once a compositional pseudo
Figure 6 Comparison of tumor populations across all generational life spans at tcritical when
symmetric CSC division frequency ps=10%. A) Time to simulation termination when ps = 10% and B)
average population size at tcritical for all rmax values and migration speeds. Non-zero migration values
demonstrate non-monotonic behavior and distinct optima at intermediate values of replicative potential.
At tcritical, model tumors from all rmax values demonstrated a wide range of sizes. C) Matching pairs of
model tumors for non-zero migration values differing only by the replicative potential of the seeding CSC.
In most cases, macroscopic appearances are so similar that analysis for CSC content would be necessary to
identify the replicative potential of the cell of tumor origin. Top: μ = 5, left rmax = 2, right rmax =5 .
Middle: μ = 10, left rmax = 3, right rmax = 7. Bottom: μ = 15, left rmax = 1, right rmax = 9. Yellow CSCs
enlarged for visibility.
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Page 9 of 13equilibrium is established, tumor growth is dominated by a fractal self-similarity asso-
ciated with self-metastatic progression as observed in previous modeling studies [10].
Conclusions
The high variance in frequency of cancer cells expressing stem cell biomarkers within
different tumors of the same tissue type can be attributed to intrinsic tumor hierarchy.
While cancer stem cells (CSCs) are the engine of tumor progression [22], the contribu-
tion of non-stem cancer cells (CCs) to tumor growth kinetics is often disregarded,
despite the fact that in many cases, these cells constitute the majority of the tumor.
We set out to investigate if and how CCs modulate CSC dynamics and thus tumor
progression. We utilized an agent-based model to describe the behavior of individual
cells in response to their local environment, and for simplicity, focused only on the
availability of space for cells to proliferate and migrate. Higher-order mechanisms,
such as mechanical forces between cells and nutrient gradients, could be included in
such a framework in the future to facilitate detailed understanding of how tumors
overcome more specific, environmentally-imposed barriers to growth. Here we limited
our analysis to the early stages of tumor development to sizes below angiogenic limita-
tions [23] and focused on interaction of cells with only their nearest neighbors, which
has been previously shown to be sufficient to reveal intriguing and often counterintui-
tive dynamics [9,10].
Much of the debate regarding the frequency of CSCs in various tumors derives from
measurements of expression of cell surface proteins and/or gene expression profiling.
Figure 7 T h er e l a t i v es i z eo ft h eC S Cc o m p a r t m e n to fmodel tumors is inversely proportional to
the generational life span of the non-stem cancer cell progeny. Top row, ps = 1%; bottom row, ps =
10%. From left to right, μ = 0, 5, 10, and 15 cell widths/day. Model tumors seeded by CSC with low
replicative potentials depended more strongly on symmetric division for macroscopic expansion and as
such comprised a higher CSC fraction than those comprising deeper mortal non-stem cancer cell
hierarchies. Early high amplitude fluctuations are attributable to the stochastic nature of growth, but in all
cases, CSC fraction approaches a pseudo steady-state composition consistent with self-metastatic
expansion.
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lead to variable expression levels of stem cell markers following clonal expansion, our
model suggests that the observed compositional heterogeneity could arise more simply
from varying the generational life spans of the CC progeny, a trait inherited from
asymmetric division of the CSCs driving tumor growth. As such, a transformation
event yielding a CSC will confer a discrete maximum proliferative capacity to the
resulting non-stem cancer cells based on a variety of factors, including tissue type [14]
and host age [24-28]. In addition, heterogeneity of telomere lengths within the cells of
a given organ at a certain age may lead to variability in tumor growth kinetics and
composition following otherwise identical origin. We have shown a direct connection
between the character of the CSC, the commensurate proliferative capacity of the non-
stem cancer cells, and the macroscopic growth kinetics and compositional heterogene-
ity of the tumor.
Interestingly, simulated tumors arising from CSCs conferring intermediate maximum
proliferative capacities demonstrated the most aggressive growth kinetics for non-zero
migration rates, resulting in a non-monotonic dependence of the growth kinetics on
the depth of the CC hierarchy. Macroscopically, this suggests an optimal balance
between the freeing of space through death of cells with exhausted replicative potential
and migration of CSCs to the resulting available space. The expansion of the immortal
CSC compartment is critical for self-metastatic tumor progression [10]. In tumors with
non-stem proliferative capacities either lower or higher than the optimum, macro-
scopic growth was less efficient. In the former case, the failure of CCs to persist before
inevitable cell death slowed total population expansion, and space resulting from CC
death opened up more quickly than the CSC population could exploit due to the infre-
quency of symmetric CSC division. In the latter case, enrichment of CSCs was inhib-
ited by crowding of the surrounding CCs, whose long generational life spans inhibit
cell activity in the tumor interior [5,9,11,29,30]. This bi-modal contribution of CCs to
tumor growth and progression yields a non-monotonic dependence of tumor growth
kinetics on CC generational life span. Optimum proliferative capacity is dependent on
the interplay of other presumably independent tumor growth kinetic parameters, such
as CSC symmetric division frequency and cell migration rate.
Tumors comprising CCs with generational life spans on either side of the optimum
proliferative capacity can grow to similar sizes yet harbor CSC fractions that vary by
multiple orders of magnitude, eventually resulting in vastly different growth kinetics.
The degree to which two presenting tumors of identical size but distinct composition
may respond differently to treatment must be considered. While tumors gaining size
early through rapid expansion of CCs with longer generational life spans may contain
only a small number of CSCs, CCs with shorter generational life spans yield later pro-
gressing tumors that may harbor many CSCs. These CSC-rich tumors have a signifi-
cantly steeper growth curve at hypothetical time of detection and thus a worse
prognosis. Comparatively self-limiting tumors arising from CSCs conferring high repli-
cative potential to their mortal progeny should have a slower progression rate and thus
experience an initial shrinkage in response to cytotoxic treatment, but the space
opened up through killing of the mortal CCs might lead to enrichment of the immor-
tal, self-metastatic CSC fraction at a rate faster than would occur naturally [31]. Con-
versely, tumors with already high fractions of CSCs are limited by the short life spans
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Page 11 of 13of the mortal progeny, such that a cytotoxic treatment would not exacerbate disease
progression through selection for the immortal compartment.
The model presented herein is based on a small number of plausible, biologically
motivated first-order assumptions. The interaction of cells has been restricted to their
immediate neighborhood, and long-range interactions achieved through physical forces
have been ignored for simplicity. Furthermore, we focused on initial tumor growth
from a single cell to a small cluster that is thought to develop without nutrient depri-
vation or physical constraints enforced by the local host environment. These model
assumptions apply to all simulations presented regardless of parameter values. As such,
we believe is valuable to compare the time intervals for model tumor progression at
different conditions in a qualitative sense only, as the translation from simulation
times to biologically accurate growth kinetics would require more mechanistic detail.
Inclusion of extrinsic forces on tumor progression is expected to further enhance the
observed behavior as modulators of the fundamental cellular level processes of prolif-
eration, migration, quiescence, and cell death, all of which are already accounted for in
the model. Further modeling efforts would be needed to explore the contribution of
applied cytotoxic pressure (with varying degrees of differential susceptibility between
the CSCs and mortal cancer cells) to overall growth kinetics and assess the role of
stored information in the tumor microenvironment in determining decision pathway
probability vectors at the cellular level.
While these model simulations begin with a single CSC, in a clinical setting, “time
zero” for the patient and physician is the onset of disease presentation rather than the
initiation event. Moreover, the number of human tumors that presents clinically is
necessarily only the aggressive fraction of the total number of tumors existing, with a
significant number likely being present in a dormant or slow-progressing state [32].
We speculate that solid tumors in a given organ with distinct CSC fractions may
demonstrate substantially different progression patterns downstream of presentation
and diagnosis, and that these differences may be attributable to the compositions in
the respective populations as governed by CC generational life span. We believe that
further exploration of the observed in silico correlation between CSC fraction and
growth kinetics in vivo may help reveal tools that augment clinical predictive power.
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